BNP Paribas Financial Markets
CALA

BNP Paribas Financial Markets’s Calithera Biosciences, Inc CALA Stock Holding History

BNP Paribas Financial Markets’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,206
Closed -$3.55K – 5010
2022
Q3 		$3.55K Buy
+1,206
New +$4.12K ﹤0.01% 4279
2022
Q2 		– Sell
-6
Closed -$49 – 4317
2022
Q1 		$49 Sell
6
-90
-94% -$920 ﹤0.01% 4107
2021
Q4 		$1.28K Buy
96
+90
+1,500% +$2.26K ﹤0.01% 4033
2021
Q3 		$262 Hold
6
– – ﹤0.01% 3946
2021
Q2 		$251 Sell
6
-426
-99% -$18.7K ﹤0.01% 3997
2021
Q1 		$20.9K Sell
432
-319
-42% -$18.6K ﹤0.01% 3750
2020
Q4 		$73.8K Sell
751
-146
-16% -$12.8K ﹤0.01% 3365
2020
Q3 		$61.9K Buy
897
+769
+601% +$67.1K ﹤0.01% 3372
2020
Q2 		$13.5K Sell
128
-717
-85% -$85.2K ﹤0.01% 3575
2020
Q1 		$75K Buy
845
+320
+61% +$38.1K ﹤0.01% 3351
2019
Q4 		$59.9K Buy
525
+177
+51% +$13.3K ﹤0.01% 3543
2019
Q3 		$21.5K Buy
348
+92
+36% +$7.37K ﹤0.01% 3923
2019
Q2 		$19.9K Sell
256
-91
-26% -$10.3K ﹤0.01% 3894
2019
Q1 		$46.7K Buy
347
+292
+531% +$30.7K ﹤0.01% 3539
2018
Q4 		$4.44K Sell
55
-1
-2% -$99 ﹤0.01% 3631
2018
Q3 		$5.88K Hold
56
– – ﹤0.01% 3977
2018
Q2 		$5.61K Sell
56
-308
-85% -$34.9K ﹤0.01% 4049
2018
Q1 		$45.9K Buy
364
+6
+2% +$936 ﹤0.01% 3611
2017
Q4 		$59.8K Buy
358
+193
+117% +$49.4K ﹤0.01% 3564
2017
Q3 		$52K Buy
165
+5
+3% +$1.58K ﹤0.01% 3127
2017
Q2 		$47.7K Buy
+160
New +$42.8K ﹤0.01% 3221
2016
Q1 		– Sell
-166
Closed -$25.4K – 3218
2015
Q4 		$25.4K Buy
166
+32
+24% +$4.8K ﹤0.01% 3207
2015
Q3 		$14.6K Buy
134
+88
+191% +$11.4K ﹤0.01% 3373
2015
Q2 		$6.58K Buy
46
+37
+411% +$8.58K ﹤0.01% 3394
2015
Q1 		$2.99K Buy
+9
New +$3.2K ﹤0.01% 3387

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets's CALA Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Calithera Biosciences, Inc (CALA) in Q4 2022, closing a stake of 1,206 shares — an estimated $3.55K sold.

BNP Paribas Financial Markets first reported a position in CALA in Q1 2015 and held it in 25 quarters. The position peaked at $75K in Q1 2020. 23 funds tracked by Wall St. Rank hold CALA as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Calithera Biosciences, Inc position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,206 Calithera Biosciences, Inc shares in Q4 2022, an estimated $3.55K.
  • BNP Paribas Financial Markets first reported a position in Calithera Biosciences, Inc in Q1 2015 and held it in 25 quarters.
  • BNP Paribas Financial Markets's Calithera Biosciences, Inc position peaked at $75K in Q1 2020.
  • 23 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.